News Updates
More Articles
- Benefits of Integrating Patient Engagement with Diversity, Equity, and Inclusion in New Medical Product Development: A Call for Action
- Drug Shortages in the Global South: A Proposed Parallel Tech and Reg Transfer Framework
- Fair Pay for Patient Engagement: Navigating the Evolving Landscape of Remuneration
- Industry’s Window to Express Interest in Africa Continental Product Evaluation Pilot Closes End of February 2024
- Accelerating Adoption of eLabeling in Singapore: One Company’s Journey
DIA Global Annual Meeting 2021: A Year Like No Other: COVID-19 and the US FDA’s Response
In June 2021, CBER Director Peter Marks and CDER Director Patrizia Cavazzoni joined Acting FDA Commissioner Janet Woodcock for the DIA 2021 Global Annual Meeting FDA Town Hall discussion to look back at whether and how the FDA, as a public health agency at its core, has risen to the many COVID-related challenges it faced.
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!